← Back to Clinical Trials
Recruiting NCT07051642

NCT07051642 Dino Study: Daily Intervention-based Research on Nurturing Opportunities in Young Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07051642
Status Recruiting
Phase —
Sponsor Tilburg University
Condition Behavior Problems in Children
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-09-15
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 8 Years
Study Type INTERVENTIONAL
Interventions
Incredible Years Dinosaur Child Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-09-15 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of the Incredible Years Dinosaur Program in children aged 4 to 8 years with conduct problems. The main questions it aims to answer are: * Does participation in the Dinosaur Child Program lead to greater improvements in children's emotional, social, and cognitive functioning, and reductions in externalizing behavior compared to a waitlist control group? * Does the intervention reduce emotional variability and daily behavior problems as captured through daily diary assessments? * Does the intervention improve daily parent-child dynamics, including reduced emotional escalation and more shared positive affect? Researchers will compare children in the intervention group to those in the waitlist control group to see if the program leads to better emotional regulation, fewer behavior problems, and improved parent-child interactions. Participants will: * Be randomly assigned to either the intervention or waitlist control group (1:1) Receive 18 weekly small-group sessions (if in the intervention condition) using the Incredible Years Dinosaur Program * Complete daily diaries with their parent using the m-Path app during a 20-week period (baseline, intervention, follow-up) * Complete standardized pre- and post-intervention assessments via parent, teacher, and child reports

Eligibility Criteria

Inclusion Criteria: * Children aged 4 to 8 years * At least one parent or primary caregiver willing and able to participate in the study and complete daily diary assessments * Sufficient Dutch language proficiency in child and parent to complete questionnaires and daily diary reports * Parental indication that the child shows elevated or (sub)clinical levels of conduct problems in daily life (e.g., frequent defiance, aggression, or rule- breaking behavior Exclusion Criteria: * Intellectual disability in the child (IQ \< 70) * Child lives primarily in a different household during weekdays (e.g., institutional care, full-time co-parenting arrangement) * Parent/child does not have sufficient Dutch language proficiency

Contact & Investigator

Central Contact

Rabia Chhangur, PhD

✉ R.R.Chhangur@tilburguniversity.edu

📞 +31 13 466 3118

Frequently Asked Questions

Who can join the NCT07051642 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 8 Years, studying Behavior Problems in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07051642 currently recruiting?

Yes, NCT07051642 is actively recruiting participants. Contact the research team at R.R.Chhangur@tilburguniversity.edu for enrollment information.

Where is the NCT07051642 trial being conducted?

This trial is being conducted at Tilburg, Netherlands.

Who is sponsoring the NCT07051642 clinical trial?

NCT07051642 is sponsored by Tilburg University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology